Motley Fool Australia

Resmed Inc. (ASX: RMD) Share Price and News

52 Week Range
1 Year Return
(20 mins delayed)

() Chart and Price Data


Share Price
Previous Close
Day Change
Monthly Average Volume
52 Week Range -
Days Range -

Resmed Inc. (ASX: RMD) Latest News

blackboard drawing of hand pointing to the words buy now

Top brokers name 3 ASX shares to buy next week

More »

woman whispering secret regarding asx share price to a man who looks surprised

2 of the best blue chip ASX shares to buy

More »

A young boy sits on his dad's shoulders while both flex their musicles, indicating ASX share price growth

2 fantastic ASX growth shares to buy this month

More »

shares valuation higher upgrade, growth shares

The latest ASX broker “buy” ideas that got a valuation upgrade

More »

asx blue chip shares represented by pile of blue casino chips in front of bar graph

2 growing blue chip ASX shares to buy today

More »

growth ASX shares, small caps

3 blue chip ASX growth shares to buy

More »

man holding mobile phone that says make donation

3 reasons why the Pushpay (ASX:PPH) share price could be a buy

More »

man holding light bulb next to growing piles of coins

3 ASX growth shares to buy right now

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size

About Resmed Inc. (ASX: RMD)

Resmed Inc. (ASX: RMD) is a global healthcare company operating in the respiratory medical device space, particularly in the treatment of sleep apnoea.

The company is headquartered in San Diego, California, and develops and manufactures medical devices and cloud-based software applications that diagnose, treat and manage a number of respiratory disorders. These include sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases.

Resmed operates in more than 140 countries worldwide and has manufacturing facilities in Australia, Singapore, France, and the United States.

Resmed first listed on the ASX on 25 Nov 1999 and is now recognised as a blue chip healthcare share on the ASX 200 index.

Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Dr Peter Craig Farrell Non-Executive Director,Non-Executive Chairman Jul 2002
Mr Ronald R Taylor Non-Executive Director Jan 2005
Mr Richard Sulpizio Non-Executive Director Aug 2005
Mr Michael J Farrell Chief Executive Officer,Executive Director Mar 2013
Ms Carol Burt Non-Executive Director Aug 2014
Ms Karen Drexler Non-Executive Director Aug 2018
Mr Jan De Witte Non-Executive Director May 2019
Ms Harjit Gill Non-Executive Director Nov 2018
Mr David Pendarvis Company Secretary
Brett Sandercock Chief Financial Officer
David Pendarvis Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Not disclosed in Annual Report 0 0.00%